Global Health Economics and Outcomes Research Market Outlook 2025-2034 by Rupal Dekate - HTML preview

Global Health Economics and Outcomes Research Market

Growth

The global Health Economics and Outcomes Research (HEOR) market is witnessing rapid growth due to the increasing need for evidence-based healthcare decisions. As healthcare systems become more complex and cost-sensitive, pharmaceutical

companies, payers, and regulatory bodies are prioritizing value-based assessments. HEOR helps stakeholders evaluate the 05

economic and clinical value of medical treatments, influencing reimbursement and policy decisions. The growing emphasis on This is a sample text. real-world data and patient-reported outcomes is further enhancing the market’s relevance in modern healthcare planning. Additionally, the rise of chronic diseases and the need for cost-effective treatment models are accelerating the adoption of HEOR services across the globe.

According to Expert Market Research, the HEOR market reached a value of USD 1.50 billion in 2024 and is projected to grow at a robust CAGR of 13.50% from 2025 to 2034, reaching USD 5.32 billion by 2034. This growth is fueled by the rising number of mergers and acquisitions among key industry players, which enhances capabilities and service reach. Expert Market Research highlights that the expansion of global clinical trials and the adoption of advanced analytical tools are playing a crucial role in shaping the market. As precision medicine and digital health evolve, HEOR will become even more integral to aligning treatment options with both economic and patient-centered outcomes. EMR also notes that the growing demand for real-world evidence is prompting companies to invest in data science and AI to refine their research strategies.

Moreover, regulatory bodies and healthcare payers are increasingly relying on HEOR data to support drug pricing and market

access decisions. Biopharmaceutical and medical device companies are integrating HEOR into product development to 01

demonstrate value to stakeholders early in the process. The growing demand for personalized therapies and better healthcare Trade Data Analysis outcomes will continue to drive investment and innovation in this space. As a result, the HEOR market is positioned for sustained expansion across developed and emerging healthcare systems worldwide.